Form 4: Arteris CEO Sells 50,000 Shares Under 10b5-1 Plan

Arteris, Inc. President and CEO, Janac K Charles, sold 50,000 shares of common stock for a weighted average price of $14.7366 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Janac K Charles, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported a sale of 50,000 shares of common stock.
• The transaction occurred on November 10, 2025, at a weighted average sale price of $14.7366 per share.
• The shares were sold in multiple transactions with prices ranging from $14.34 to $14.95.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Charles on March 5, 2025.
• Following the transaction, Mr. Charles directly beneficially owns 161,759 shares of common stock.
• Indirect beneficial ownership includes 9,639,071 shares through Bayview Legacy, LLC, where Mr. Charles is the manager, and 56,252 shares through the Charles and Lydia Janac Trust, for which he serves as trustee.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a significant insider sale by the CEO. However, the pre-arranged 10b5-1 plan mitigates the immediate negative signal, suggesting a planned liquidity event rather than a reaction to new adverse information.

Positives

• The sale was conducted under a pre-arranged 10b5-1 trading plan, adopted on March 5, 2025, indicating a planned liquidity event rather than a reaction to recent negative developments.

Negatives

• A significant insider sale by the President and CEO, Director, and 10% Owner could be perceived negatively by the market, potentially signaling a lack of confidence or a desire for personal liquidity.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The transaction was made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.
• The price reported is a weighted average sale price, with shares sold in multiple transactions ranging from $14.34 to $14.95.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The reporting person has indirect beneficial ownership of 9,639,071 shares through Bayview Legacy, LLC, where they serve as manager.
• The reporting person has indirect beneficial ownership of 56,252 shares through the Charles and Lydia Janac Trust, for which they serve as trustee.

Stakeholder Impact

• Shareholders may interpret the CEO's sale of a significant number of shares as a negative signal, potentially impacting investor confidence and the company's stock price.
• The pre-planned nature of the sale (10b5-1 plan) may alleviate some concerns by indicating a scheduled personal financial event rather than a reaction to new company-specific information.

Key Dates

Recommendation

The sale by the President and CEO, while significant in volume, was executed under a pre-arranged 10b5-1 trading plan. This suggests a planned liquidity event rather than a reaction to new material non-public information, which mitigates the immediate negative signal typically associated with insider selling. Therefore, a 'hold' recommendation is appropriate based solely on this filing, advising investors to monitor future filings and company performance for further insights.

Keywords

Arteris, AIP, insider trading, Form 4, stock sale, CEO, 10b5-1 plan, common stock, beneficial ownership